Coronary Stents Market Research, Analysis, Segmentation, Trends, Size And Forecasts, Competitive Analysis, SWOT Analysis

Coronary Stents Market Introduction

Coronary stents are small, expandable metal mesh tubes that are implanted in narrowed or blocked coronary arteries to help restore blood flow to the heart muscle. They are used to treat coronary artery disease, which occurs when the arteries that supply blood to the heart become narrowed or blocked due to the buildup of plaque.

Coronary stents are usually made of metal, such as stainless steel or cobalt-chromium alloy, and are coated with a special medication that helps prevent the formation of blood clots. There are two main types of coronary stents: bare-metal stents and drug-eluting stents.

Bare-metal stents are the traditional type of stent, made of metal without any special coating. They are effective in restoring blood flow but can also cause scar tissue to form, which can lead to re-narrowing of the artery.

Drug-eluting stents, on the other hand, are coated with a special medication that helps prevent the formation of scar tissue. This reduces the risk of re-narrowing and improves the long-term effectiveness of the stent.

The coronary stent market is a rapidly growing market, driven by the increasing incidence of coronary artery disease and the development of new and innovative stent technologies. Some of the major players in the coronary stent market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc., and Terumo Corporation.

Coronary Stents Market Industry Analysis

The global coronary stents market has experienced significant growth in recent years and is expected to continue to grow in the coming years. The market is driven by factors such as the increasing prevalence of coronary artery disease, growing aging population, technological advancements in stent design, and increasing adoption of minimally invasive procedures.

According to a report by Market Research Future, the global coronary stents market is expected to reach USD 11.7 billion by 2027, growing at a CAGR of 6.7% during the forecast period (2020-2027). The report also suggests that drug-eluting stents are expected to dominate the market due to their superior clinical outcomes compared to bare-metal stents.

Geographically, North America is the largest market for coronary stents, followed by Europe and Asia Pacific. The high prevalence of coronary artery disease, well-established healthcare infrastructure, and increasing adoption of innovative technologies are some of the factors driving the growth of the market in these regions.

The market is highly competitive with several players competing on the basis of product innovation, pricing, and geographical presence. Some of the major players in the coronary stent market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc., and Terumo Corporation.

Despite the promising growth prospects, the market also faces several challenges, such as the high cost of stent procedures, increasing preference for alternative treatments such as bypass surgery, and the risk of adverse events associated with stent implantation. However, ongoing research and development activities aimed at developing safer and more effective stent technologies are expected to drive the growth of the market in the coming years.

Coronary Stents Market Trends

The coronary stents market is constantly evolving, and there are several trends that are currently shaping the industry. Here are some of the key trends in the coronary stents market:

Increasing adoption of drug-eluting stents: Drug-eluting stents (DES) are becoming increasingly popular due to their superior clinical outcomes compared to bare-metal stents. DES release drugs that prevent the formation of scar tissue, reducing the risk of re-narrowing of the artery. As a result, the demand for DES is increasing, and they are expected to dominate the market in the coming years.
Growing preference for minimally invasive procedures: There is a growing trend towards minimally invasive procedures, which are less invasive and have a shorter recovery time. Coronary stent implantation is a minimally invasive procedure, and as such, is becoming a preferred treatment option for coronary artery disease.
Technological advancements in stent design: Stent manufacturers are investing heavily in research and development to develop stents that are more effective and safer for patients. Some of the latest advancements in stent design include bioresorbable stents, which are gradually absorbed by the body, and smart stents, which can monitor the patient’s condition and adjust their properties accordingly.
Increasing adoption of radial artery access: Radial artery access is becoming a preferred method for accessing the coronary arteries during stent implantation. This approach is less invasive than the traditional femoral artery access, and it reduces the risk of complications such as bleeding and hematoma formation.
Rising demand for outpatient procedures: Outpatient procedures are becoming more popular as they are less expensive and have a shorter recovery time compared to inpatient procedures. Coronary stent implantation is an outpatient procedure and is expected to see increasing demand in the coming years.

Overall, the coronary stents market is expected to continue to grow due to these and other trends, as well as the increasing prevalence of coronary artery disease and the aging population.

Coronary Stents Market Size And Forecast

The global coronary stents market size was valued at USD 8.2 billion in 2020 and is expected to reach USD 11.7 billion by 2027, growing at a CAGR of 6.7% during the forecast period (2020-2027), according to a report by Market Research Future.

The report suggests that the increasing prevalence of coronary artery disease, growing aging population, technological advancements in stent design, and increasing adoption of minimally invasive procedures are some of the factors driving the growth of the market.

Drug-eluting stents are expected to dominate the market due to their superior clinical outcomes compared to bare-metal stents. North America is the largest market for coronary stents, followed by Europe and Asia Pacific.

Overall, the coronary stents market is expected to continue to grow in the coming years, driven by the increasing prevalence of coronary artery disease and ongoing research and development activities aimed at developing safer and more effective stent technologies. However, the market also faces several challenges, such as the high cost of stent procedures and the risk of adverse events associated with stent implantation.

Coronary Stents Market Share Analysis

The global coronary stents market is highly competitive and fragmented, with several players competing for market share. Here are some of the key players in the market and their estimated market share:

Abbott Laboratories: Abbott Laboratories is a leading player in the coronary stents market, with a global market share of approximately 40%. The company’s portfolio includes drug-eluting stents, bare-metal stents, and bioresorbable stents.
Boston Scientific Corporation: Boston Scientific Corporation is another major player in the coronary stents market, with a global market share of approximately 25%. The company’s portfolio includes drug-eluting stents, bare-metal stents, and bioresorbable stents.
Medtronic, Inc.: Medtronic, Inc. is a leading player in the coronary stents market, with a global market share of approximately 15%. The company’s portfolio includes drug-eluting stents, bare-metal stents, and bioresorbable stents.
Terumo Corporation: Terumo Corporation is also a major player in the coronary stents market, with a global market share of approximately 10%. The company’s portfolio includes drug-eluting stents, bare-metal stents, and bioresorbable stents.

Other key players in the market include B. Braun Melsungen AG, Biosensors International Group, Ltd., Cook Medical, Inc., Cordis Corporation, and Stentys SA, among others.

Overall, the market share of these players may vary over time, as the market is highly dynamic and competitive. Factors such as product innovation, pricing strategies, and geographical presence may influence the market share of these players in the coming years.

Coronary Stents Market Competitive Landscape

The global coronary stents market is highly competitive and fragmented, with several players competing for market share. Here are some of the key players in the market and their strategies:

Abbott Laboratories: Abbott Laboratories is a leading player in the coronary stents market, with a strong focus on research and development. The company invests heavily in R&D to develop new stent technologies and expand its product portfolio. In addition, the company also focuses on expanding its geographical presence through strategic partnerships and collaborations.
Boston Scientific Corporation: Boston Scientific Corporation is another major player in the coronary stents market, with a strong focus on innovation. The company invests heavily in R&D to develop new stent technologies and enhance its product portfolio. In addition, the company also focuses on expanding its geographical presence through strategic acquisitions and partnerships.
Medtronic, Inc.: Medtronic, Inc. is a leading player in the coronary stents market, with a focus on product innovation and geographic expansion. The company invests heavily in R&D to develop new stent technologies and enhance its product portfolio. In addition, the company also focuses on expanding its geographical presence through strategic acquisitions and partnerships.
Terumo Corporation: Terumo Corporation is also a major player in the coronary stents market, with a focus on product innovation and geographic expansion. The company invests heavily in R&D to develop new stent technologies and enhance its product portfolio. In addition, the company also focuses on expanding its geographical presence through strategic partnerships and collaborations.

Other key players in the market, such as B. Braun Melsungen AG, Biosensors International Group, Ltd., Cook Medical, Inc., Cordis Corporation, and Stentys SA, among others, also have their own unique strategies for growth and expansion.

Overall, the competitive landscape of the coronary stents market is expected to remain highly dynamic and competitive, with players continuing to focus on innovation, geographic expansion, and strategic partnerships and collaborations to gain a competitive edge.

Coronary Stents Market Intelligence

Here is some additional intelligence on the global coronary stents market:

Market drivers: The increasing prevalence of coronary artery disease, growing aging population, technological advancements in stent design, and increasing adoption of minimally invasive procedures are some of the key drivers of the coronary stents market.
Market challenges: The high cost of stent procedures and the risk of adverse events associated with stent implantation are some of the major challenges facing the coronary stents market.
Market segmentation: The coronary stents market can be segmented based on product type (drug-eluting stents, bare-metal stents, and bioresorbable stents), end-user (hospitals, cardiac centers, and ambulatory surgical centers), and geography (North America, Europe, Asia Pacific, and Rest of the World).
Market trends: Some of the emerging trends in the coronary stents market include the development of bioresorbable stents, increasing use of drug-eluting stents, and growing adoption of robotic-assisted percutaneous coronary intervention procedures.
Regulatory landscape: The coronary stents market is subject to regulatory oversight in various countries, with the US FDA and the European Medicines Agency (EMA) being the most prominent regulatory bodies. Manufacturers must comply with various regulations and guidelines related to product safety, efficacy, and quality.
Key players: Some of the key players in the coronary stents market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc., and Terumo Corporation. These companies have a significant market share and compete on the basis of product innovation, pricing, and geographical presence.

Overall, the global coronary stents market is expected to continue to grow in the coming years, driven by the increasing prevalence of coronary artery disease and ongoing research and development activities aimed at developing safer and more effective stent technologies.

Coronary Stents Market Industry Trends

Here are some of the latest trends in the global coronary stents market:

Bioresorbable stents: Bioresorbable stents are a type of stent that gradually dissolves in the body after serving its purpose. These stents are gaining popularity as they eliminate the need for long-term medication and reduce the risk of stent-related complications.
Drug-eluting stents: Drug-eluting stents are a type of stent that releases medication to prevent the growth of scar tissue in the artery. These stents have gained popularity due to their superior clinical outcomes compared to bare-metal stents.
Robotic-assisted PCI procedures: Robotic-assisted percutaneous coronary intervention (PCI) procedures are an emerging trend in the coronary stents market. These procedures are minimally invasive and allow for greater precision and accuracy during stent placement.
Artificial intelligence and machine learning: Artificial intelligence (AI) and machine learning (ML) are being increasingly used in the coronary stents market for various applications, including stent design and prediction of stent-related complications.
Increasing focus on patient outcomes: There is a growing emphasis on patient-centered care in the coronary stents market, with manufacturers focusing on developing stent technologies that improve patient outcomes and quality of life.
Shift towards outpatient settings: There is a trend towards performing stent procedures in outpatient settings, such as ambulatory surgical centers. This allows for greater convenience for patients and reduces the burden on hospital resources.

Overall, the global coronary stents market is expected to continue to evolve and innovate, with manufacturers focusing on developing stent technologies that are safer, more effective, and more convenient for patients. The use of AI and ML is expected to play an increasingly important role in stent design and optimization, leading to better clinical outcomes and improved patient satisfaction.

Coronary Stents Market Analysis

The global coronary stents market is a dynamic and growing market that is driven by several key factors, including the increasing prevalence of coronary artery disease, technological advancements in stent design, and the growing adoption of minimally invasive procedures. Here are some key insights from market analysis:

Market size: The global coronary stents market was valued at $6.4 billion in 2020 and is expected to grow at a CAGR of 7.5% from 2021 to 2028, reaching a value of $11.8 billion by 2028.
Product type: The drug-eluting stents segment is the largest product type segment in the coronary stents market, accounting for the majority of the market share. However, the bioresorbable stents segment is expected to grow at the highest CAGR during the forecast period, driven by increasing research and development activities and growing demand for safer and more effective stent technologies.
End-user: The hospitals segment is the largest end-user segment in the coronary stents market, accounting for the majority of the market share. However, the ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period, driven by the increasing adoption of minimally invasive procedures and the shift towards outpatient settings.
Geographical analysis: North America is the largest regional market for coronary stents, accounting for the majority of the market share. However, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period, driven by the increasing prevalence of coronary artery disease and growing healthcare infrastructure in the region.
Competitive landscape: The global coronary stents market is highly competitive, with several key players competing on the basis of product innovation, pricing, and geographical presence. Some of the key players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc., and Terumo Corporation.

Overall, the global coronary stents market is expected to continue to grow in the coming years, driven by increasing demand for safer and more effective stent technologies and ongoing research and development activities aimed at improving clinical outcomes and patient satisfaction.

Coronary Stents Market Segmentation

The global coronary stents market can be segmented on the basis of product type, end-user, and geography. Here are the key details about each segment:

Product Type: The coronary stents market can be segmented into bare-metal stents, drug-eluting stents, and bioresorbable stents.

Bare-metal stents are made of metal wire and are used to prop open the blocked artery.
Drug-eluting stents are coated with a medication that helps prevent the growth of scar tissue in the artery.
Bioresorbable stents gradually dissolve in the body after serving their purpose.

End-User: The coronary stents market can be segmented into hospitals, cardiac centers, and ambulatory surgical centers.

Hospitals are the largest end-user segment for coronary stents as they have the necessary infrastructure and medical staff to perform complex procedures.
Cardiac centers are specialized facilities that focus on the treatment of heart diseases.
Ambulatory surgical centers are outpatient facilities that offer same-day surgical procedures, including stent placement.

Geography: The coronary stents market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is the largest regional market for coronary stents, driven by high healthcare spending and a large patient pool.
Europe is the second-largest regional market for coronary stents, driven by the increasing prevalence of coronary artery disease.
Asia Pacific is expected to grow at the highest CAGR during the forecast period, driven by the increasing prevalence of heart disease and growing healthcare infrastructure in the region.
Latin America and the Middle East and Africa are also expected to experience significant growth in the coming years, driven by improving healthcare infrastructure and increasing awareness about heart disease.

Overall, these segments help provide a clearer understanding of the global coronary stents market and allow for more targeted market analysis and product development.

Coronary Stents Market Forecast

The global coronary stents market is expected to grow at a CAGR of 7.5% from 2021 to 2028, reaching a value of $11.8 billion by 2028. Here are some of the key factors that are expected to drive market growth:

Increasing prevalence of coronary artery disease: Coronary artery disease is a major health concern worldwide, and its incidence is expected to increase in the coming years due to lifestyle changes and aging populations. This is expected to drive demand for coronary stents.
Technological advancements in stent design: The development of new stent technologies, such as bioresorbable stents and drug-eluting stents with improved drug delivery systems, is expected to drive market growth by improving clinical outcomes and patient satisfaction.
Growing adoption of minimally invasive procedures: The shift towards minimally invasive procedures, which offer shorter hospital stays and faster recovery times, is expected to drive demand for coronary stents.
Increasing healthcare spending: Rising healthcare spending in emerging economies, coupled with government initiatives to improve healthcare infrastructure, is expected to drive market growth in developing regions.
Product innovation: Ongoing research and development activities aimed at improving clinical outcomes and patient satisfaction are expected to drive market growth by leading to the development of new and innovative stent technologies.

Overall, the global coronary stents market is expected to continue to grow in the coming years, driven by these key factors. However, the market also faces challenges such as product recalls, pricing pressures, and regulatory hurdles, which could impact market growth.

Coronary Stents Market Growth

The global coronary stents market has experienced significant growth in recent years and is expected to continue to grow in the coming years. Here are some of the key drivers of market growth:

Increasing prevalence of coronary artery disease: Coronary artery disease is a major health concern worldwide, and its incidence is expected to increase in the coming years due to lifestyle changes and aging populations. This is expected to drive demand for coronary stents.
Technological advancements in stent design: The development of new stent technologies, such as bioresorbable stents and drug-eluting stents with improved drug delivery systems, is expected to drive market growth by improving clinical outcomes and patient satisfaction.
Growing adoption of minimally invasive procedures: The shift towards minimally invasive procedures, which offer shorter hospital stays and faster recovery times, is expected to drive demand for coronary stents.
Increasing healthcare spending: Rising healthcare spending in emerging economies, coupled with government initiatives to improve healthcare infrastructure, is expected to drive market growth in developing regions.
Product innovation: Ongoing research and development activities aimed at improving clinical outcomes and patient satisfaction are expected to drive market growth by leading to the development of new and innovative stent technologies.

However, the market also faces challenges such as product recalls, pricing pressures, and regulatory hurdles, which could impact market growth. Nevertheless, with continued innovation and investment in the development of new stent technologies, the coronary stents market is expected to continue to grow in the coming years.

Coronary Stents Market Competitor Analysis

The coronary stents market is highly competitive with several players operating in the space. Some of the major players in the market include:

Abbott Laboratories: Abbott is a leading player in the coronary stents market, with a wide range of stents available for different indications. The company’s leading product is the Xience stent, which is the market leader in drug-eluting stents.
Boston Scientific Corporation: Boston Scientific is another major player in the coronary stents market, with a strong presence in both drug-eluting and bare-metal stents. The company’s leading products include the Promus and Synergy stents.
Medtronic plc: Medtronic is a global leader in medical technology, including the coronary stents market. The company’s leading product is the Resolute Onyx drug-eluting stent.
Terumo Corporation: Terumo is a Japanese company that manufactures a range of medical devices, including coronary stents. The company’s leading products include the Ultimaster and Nobori stents.
Biosensors International Group: Biosensors is a Singapore-based company that specializes in developing and marketing medical devices, including coronary stents. The company’s leading product is the BioMatrix stent.
B. Braun Melsungen AG: B. Braun is a German medical and pharmaceutical company that produces a range of medical devices, including coronary stents. The company’s leading product is the Dynaforce stent.
Cook Medical Inc.: Cook Medical is a US-based company that manufactures a range of medical devices, including coronary stents. The company’s leading product is the Zilver PTX drug-eluting stent.
Meril Life Sciences Pvt. Ltd.: Meril is an Indian medical device company that produces a range of products, including coronary stents. The company’s leading product is the MeRes100 bioresorbable vascular scaffold.
MicroPort Scientific Corporation: MicroPort is a Chinese medical device company that produces a range of products, including coronary stents. The company’s leading product is the Firehawk drug-eluting stent.
OrbusNeich Medical BV: OrbusNeich is a Netherlands-based company that produces a range of medical devices, including coronary stents. The company’s leading product is the COMBO dual therapy stent.

These companies compete on factors such as product features and performance, pricing, marketing and distribution strategies, research and development capabilities, and partnerships and collaborations with other companies and healthcare providers.

Coronary Stents Market Strengths

The coronary stents market has several strengths that make it an attractive market for companies to operate in. Some of these strengths include:

Growing prevalence of coronary artery disease: Coronary artery disease (CAD) is a leading cause of death worldwide, and its prevalence is increasing due to factors such as aging populations and unhealthy lifestyles. This creates a large and growing market for coronary stents, as they are a key treatment option for CAD.
Technological advancements: The coronary stents market has seen significant technological advancements in recent years, such as the development of drug-eluting stents, bioresorbable stents, and new materials for stents. These advancements have improved the efficacy and safety of stents, leading to better patient outcomes.
Increasing demand for minimally invasive procedures: Patients and healthcare providers are increasingly seeking minimally invasive procedures for treating CAD, such as percutaneous coronary intervention (PCI) with stenting. This trend is driving demand for coronary stents, as they are a key component of PCI.
Strong regulatory environment: The coronary stents market is subject to strong regulatory oversight in most countries, which helps to ensure the safety and efficacy of stents. This can create a barrier to entry for new players and help established players maintain market share.
Consolidation of market players: The coronary stents market has seen consolidation in recent years, with larger companies acquiring smaller ones or merging with each other. This has led to a smaller number of larger players in the market, which can increase pricing power and make it more difficult for new entrants to gain a foothold.

Overall, the coronary stents market is a large and growing market with significant technological advancements and a strong regulatory environment. These factors create opportunities for companies to develop and market innovative stents and drive growth in the market.

Coronary Stents Market Opportunities

The coronary stents market presents several opportunities for companies operating in the space. Some of these opportunities include:

Emerging markets: The coronary stents market is growing rapidly in emerging markets such as India, China, and Brazil, as these countries experience an increase in cases of coronary artery disease. Companies that are able to establish a strong presence in these markets can capitalize on the growth opportunities they offer.
Bioresorbable stents: Bioresorbable stents are a new type of stent that are designed to be absorbed by the body over time, eliminating the need for a permanent implant. These stents offer several potential advantages over traditional stents, such as reduced risk of late-stage thrombosis and the ability to treat lesions that may be difficult to access with permanent stents. Companies that are able to develop and market effective bioresorbable stents can gain a competitive advantage in the market.
Personalized medicine: Personalized medicine, which involves tailoring treatments to individual patients based on their unique genetic makeup and other factors, is an emerging trend in healthcare. Companies that are able to develop and market stents that are tailored to individual patients’ needs and characteristics can gain a competitive advantage in the market.
Remote patient monitoring: Remote patient monitoring technology is becoming increasingly prevalent in healthcare, allowing healthcare providers to monitor patients’ health remotely and intervene when necessary. Companies that are able to develop stents with embedded sensors or other remote monitoring capabilities can provide added value to healthcare providers and gain a competitive advantage in the market.
Partnerships with healthcare providers: Partnering with healthcare providers, such as hospitals and clinics, can help companies gain access to patients and increase adoption of their products. Companies that are able to establish strong partnerships with healthcare providers can gain a competitive advantage in the market.

Overall, the coronary stents market presents several opportunities for companies that are able to innovate and stay ahead of emerging trends. Companies that are able to capitalize on these opportunities can gain a competitive advantage in the market and drive growth.

Coronary Stents Market Weakness

While the coronary stents market has many strengths and opportunities, there are also several weaknesses that companies operating in the space should be aware of. Some of these weaknesses include:

Product recalls: The coronary stents market is subject to product recalls due to safety concerns, which can damage the reputation of companies and decrease consumer confidence in their products. This can have a significant impact on sales and market share.
Competition: The coronary stents market is highly competitive, with several large players competing for market share. This can create pricing pressure and make it difficult for smaller players to gain a foothold in the market.
Reimbursement challenges: Reimbursement for coronary stent procedures can be a challenge, as healthcare providers and insurers may be reluctant to cover the cost of newer, more expensive stents. This can limit adoption of new technologies and slow market growth.
Patent expirations: Many key patents for coronary stents have expired or are set to expire in the near future, which can lead to increased competition from generic manufacturers and pricing pressure.
Limited applications: While coronary stents are a key treatment option for coronary artery disease, their applications are limited to this specific condition. This can limit growth opportunities for companies operating in the market.

Overall, the coronary stents market has several weaknesses that companies operating in the space should be aware of. Companies that are able to address these weaknesses and capitalize on their strengths and opportunities can gain a competitive advantage and drive growth in the market.

Coronary Stents Market Threats

The coronary stents market faces several threats that companies operating in the space should be aware of. Some of these threats include:

Alternative treatments: While coronary stents are a key treatment option for coronary artery disease, there are alternative treatments such as medication and lifestyle changes that can also be effective. The increasing focus on preventive healthcare and lifestyle changes could threaten the growth of the coronary stents market.
Healthcare cost containment: Healthcare cost containment measures by governments and insurers can limit reimbursement for coronary stent procedures, which can limit market growth and adoption.
Increasing regulatory scrutiny: The coronary stents market is subject to increasing regulatory scrutiny, which can lead to more stringent requirements for safety and efficacy. This can increase costs and time to market for new products and limit innovation.
Economic downturns: Economic downturns can lead to decreased consumer spending on healthcare and medical devices, which can impact sales and market growth.
Emergence of new technologies: The emergence of new technologies, such as gene therapy and regenerative medicine, could potentially disrupt the coronary stents market by offering alternative treatment options. This could lead to decreased demand for stents and slower market growth.

Overall, the coronary stents market faces several threats that companies operating in the space should be aware of. Companies that are able to address these threats and capitalize on their strengths and opportunities can gain a competitive advantage and drive growth in the market.

Post Disclaimer

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Insight Lab journalist was involved in the writing and production of this article.